Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 26, 1998

View Archived Issues

YM-175 treatment reduces alveolar bone loss in dogs with periodontitis

Incyte to acquire Hexagen and its technology for detecting SNPs

International team identifies compounds for treating slow-growing tumors

Life Medical Sciences: Q2 1998 highlights

GelTex: Q2 1998 highlights

Aphton patents its vaccine-like technology based on the neutralization of gastrin

Rebetron receives priority review status

Antidiabetes drug from Amylin enters phase I clinical study

Incert appears to prevent the formation of postoperative adhesions

Pagoclone reduces frequency of panic attacks in patients with panic disorder

TAN-2421-A1: a novel xanthine derivative with immunomodulating activity

British Biotech claims MMP inhibitors for blocking connective tissue degradation

Dual 5-HT reuptake inhibitors/5-HT1A antagonists with potential as antidepressants

Neuroprotective glutamate receptor antagonists disclosed by Warner-Lambert

Pfizer discovers new treatments for atherosclerosis and related disorders

Allelix research into antimigraine compounds proves fruitful

ACS news flash: Rhone-Poulenc Rorer studies dual PDE4/MMP inhibitors

Parke-Davis synthesizes potent and selective D4 ligands with antipsychotic potential

News from ACS: PD-180988 is a potent and selective ETA antagonist

Selective MMP-3 inhibitor PS-508 described at ACS meeting

SSRI produces significant improvements in patients with social phobia

Agouron's HIV protease inhibitor approved for marketing in Canada

Bio-Technology General in-licenses PEG-uricase for development

IMpact-RSV trial results announced at international congress

Advisory committee recommends European approval for Viagra

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...